Why the study?
Does encainide prevent recurrence of ventricular tachycardia in patients with refractory recurrent ventricular tachycardia?
Population
38 patients with recurrent, strikingly drug-refractory ventricular tachycardia.
Design
Case_series
Follow-up
mean 4.2 months
Authors
Loading...
May support encainide in refractory VT; hypothesis-generating and should not yet change practice.
Does encainide prevent recurrence of ventricular tachycardia in patients with refractory recurrent ventricular tachycardia?
Encainide completely eliminated recurrence of ventricular tachycardia in 54% of patients at 6 months, demonstrating efficacy in drug-refractory cases despite some proarrhythmic risk.
Mason et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: